LENDLEASE PHARMACEUTICAL ASIA PTE. LTD.

Business Description

LENDLEASE PHARMACEUTICAL ASIA PTE. LTD. is registered as a business entity on 12 March 1997 (28.1 years ago) structured as a Private Company Limited By Shares (Local Company) with 6 officer(s) in-charge. The business jurisdiction is overseen by the Accounting and Corporate Regulatory Authority (ACRA), a government agency from Singapore with the given Business Registration Number / Unique Entity Number (UEN) 199701564W. The business official address is located at 600 North Bridge Road #23-01, Parkview Square, Singapore 188778 with main trading activity as Project Managers In The Construction Industry in the primary industry of 71121: General Building Engineering Design And Consultancy Services using Singapore Dollars - SGD as its default trading currency. The business legal name has undergone change(s) and is previously known as OAKWOOD ASIA PACIFIC PTE. LTD., LEND LEASE INVESTMENTS PTE LTD, BOVIS LEND LEASE PHARMACEUTICAL PTE. LTD., LEND LEASE PROJECT MANAGEMENT & CONSTRUCTION PHARMACEUTICAL ASIA PTE. LTD., LEND LEASE PHARMACEUTICAL ASIA PTE. LTD.. The business annual account filing date falls on 31 January and is no longer operational with the status of 'Dissolved - Members' Voluntary Winding Up'. The business paid up share capital is SGD NaN, with preference share capital of SGD NaN, and other share capital at SGD NaN.

In the past 365 days, LENDLEASE PHARMACEUTICAL ASIA PTE. LTD. has received a total of Login to view reported payment review(s). 0 were rated Good and Login to view were rated Poor. Therefore no payment reviews were made recently. The aggregated good payment amount is equivalent to USD 0, and aggregated poor payment amount is equivalent to USD Login to view. Its current payment rating of "D" suggest a bad payment culture where settlement with stakeholders is frequently past due. Since the business is no longer active, please take caution if you continue transacting as a counter-party. The appointment of KPMG LLP as auditor indicates that the business is medium to large sized as it is required to meet additional regulatory requirements either due to reported revenue or assets exceeding SGD 10 million or has more than 50 employees in the previous two fiscal years.

LENDLEASE PHARMACEUTICAL ASIA PTE. LTD. is not yet a Prompt Payment Initiative Signatory.

Last updated on 30 April 2023